512 Recruiting Trials

Clinical Trials
in Rhode Island

Browse 512 recruiting clinical trials currently enrolling participants in Rhode Island. Search by condition to find trials you may qualify for, at no cost.

Showing 15 of 512 recruiting trials in Rhode Island

Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
PHASE3 Anchorage, Alaska +4 sites · Stage IV Lung Cancer AJCC v8, Stage IIIB Lung Cancer AJCC v8
Recruiting
Evaluating the Addition of the Immunotherapy Drug Atezolizumab to Standard Chemotherapy Treatment for Advanced or Metastatic Neuroendocrine Carcinomas That Originate Outside the Lung
PHASE2 Anchorage, Alaska +4 sites · Advanced Extrapulmonary Neuroendocrine Carcinoma, Metastatic Extrapulmonary Neuroendocrine Carcinoma
Recruiting
Platform of Randomized Adaptive Clinical Trials in Critical Illness
NA Tucson, Arizona +4 sites · Respiratory Insufficiency, Extracorporeal Membrane Oxygenation Complication
Recruiting
A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab
PHASE3 Birmingham, Alabama +4 sites · Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8
Recruiting
A Study of DS-1103a Combination Therapy in Participants With Advanced Solid Tumors
PHASE1 Sarasota, Florida +4 sites · Advanced Solid Tumor
Recruiting
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer
PHASE3 Birmingham, Alabama +4 sites · Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8
Recruiting
Recruiting
Prevention/Reduction of ASRs and PTSD to Sustain Civilian Performance With Sublingual Cyclobenzaprine HCl (TNX-102 SL)
PHASE2 Birmingham, Alabama +4 sites · Acute Stress Reaction, Neurocognitive Function
Recruiting
The Progressive Supranuclear Palsy Clinical Trial Platform
PHASE2 Sun City, Arizona +4 sites · Progressive Supranuclear Palsy(PSP)
Recruiting
Study of AZD0516 as Monotherapy and in Combination in Participants With Metastatic Prostate Cancer
PHASE1 Fayetteville, Arkansas +4 sites · Metastatic Prostate Cancer
Recruiting